Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
SERS and MD simulation studies of a kinase inhibitor demonstrate the emergence of a potential drug discovery tool
KTH, School of Biotechnology (BIO), Theoretical Chemistry and Biology.
Show others and affiliations
2014 (English)In: Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, E-ISSN 1091-6490, Vol. 111, no 29, 10416-10421 p.Article in journal (Refereed) Published
Abstract [en]

We demonstrate the use of surface-enhanced Raman spectroscopy (SERS) as an excellent tool for identifying the binding site of small molecules on a therapeutically important protein. As an example, we show the specific binding of the common antihypertension drug felodipine to the oncogenic Aurora A kinase protein via hydrogen bonding interactions with Tyr-212 residue to specifically inhibit its activity. Based on SERS studies, molecular docking, molecular dynamics simulation, biochemical assays, and point mutation-based validation, we demonstrate the surface-binding mode of this molecule in two similar hydrophobic pockets in the Aurora A kinase. These binding pockets comprise the same unique hydrophobic patches that may aid in distinguishing human Aurora A versus human Aurora B kinase in vivo. The application of SERS to identify the specific interactions between small molecules and therapeutically important proteins by differentiating competitive and noncompetitive inhibition demonstrates its ability as a complementary technique. We also present felodipine as a specific inhibitor for oncogenic Aurora A kinase. Felodipine retards the rate of tumor progression in a xenografted nude mice model. This study reveals a potential surface pocket that may be useful for developing small molecules by selectively targeting the Aurora family kinases.

Place, publisher, year, edition, pages
2014. Vol. 111, no 29, 10416-10421 p.
Keyword [en]
vibrational spectroscopy, structure-activity relationship, ligand binding
National Category
Medical Biotechnology
Identifiers
URN: urn:nbn:se:kth:diva-149506DOI: 10.1073/pnas.1402695111ISI: 000339310700021Scopus ID: 2-s2.0-84904659991OAI: oai:DiVA.org:kth-149506DiVA: diva2:739976
Note

QC 20140822

Available from: 2014-08-22 Created: 2014-08-22 Last updated: 2017-12-05Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textScopus

Authority records BETA

Ågren, Hans

Search in DiVA

By author/editor
Perumal, Sathya S. R. R.Ågren, Hans
By organisation
Theoretical Chemistry and Biology
In the same journal
Proceedings of the National Academy of Sciences of the United States of America
Medical Biotechnology

Search outside of DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 61 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf